Apple’s latest update to the AirPods Pro 2 has sparked major discussion in the wearable health tech sector, with the UK officially recognising them as certified hearing aids under the Medical Devices Regulations 2002. This development marks a significant milestone in the evolution of consumer health devices and raises important questions about regulation, accessibility, and the future of healthcare innovation.

From wireless earbuds to medical devices

The Conversation Boost and Live Listen features now enable AirPods Pro 2 to function as over-the-counter hearing aids, supporting individuals with mild to moderate hearing loss. While these capabilities have been available in the United States under FDA regulation, their UK certification introduces new layers of oversight under the MHRA’s framework for medical devices.

This transition from consumer gadget to health device reflects a broader trend: the growing convergence of mainstream electronics and regulated healthcare tools. As wearable health tech becomes more sophisticated, its role in preventative care and patient support is expanding rapidly.

Regulatory implications: what’s next?

Apple’s reclassification of the AirPods has triggered wider debate across the UK medical and technology sectors. Several critical regulatory issues are now in focus:

  • Device classification: Will other multifunctional wearables now fall under medical device regulation, requiring companies to comply with more rigorous standards?

  • Data governance: With wearables collecting sensitive health metrics, how will GDPR and MHRA policies adapt to safeguard users?

  • Market disruption: Traditional hearing aid manufacturers are facing competition from consumer tech companies that can deliver similar functionality with broader appeal and distribution.

To understand more about how medical devices are classified in the UK, the MHRA’s guidance provides a comprehensive overview of the evolving regulatory landscape.

A sign of things to come in wearable health tech

Apple’s move is likely just the beginning. Tech giants are increasingly integrating health-focused features into their devices, offering scalable, low-cost alternatives to traditional medical equipment. This raises opportunities for early intervention and broader access, but also demands rigorous safety, efficacy, and ethical data use.

As wearable health tech grows in capability and popularity, stakeholders across healthcare, technology, and policy must collaborate to ensure innovation aligns with regulation. Striking the right balance will be essential to protect users and support sustainable growth in this hybrid sector.

Let’s chat about the issues affecting you. Click here to get in touch.

Back to News + Insights